Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
27.25
-0.03 (-0.11%)
Streaming Delayed Price
Updated: 10:27 AM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GeneDx Holdings Corp. - Class A Common Stock
< Previous
1
2
3
4
Next >
GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium
June 28, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
June 26, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
June 20, 2023
Eight state Medicaid programs now cover rWGS in the pediatric inpatient setting, with active bills in other states
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Recap: GeneDx Hldgs Q1 Earnings
May 09, 2023
Via
Benzinga
Earnings Preview: GeneDx Hldgs
May 08, 2023
Via
Benzinga
Why Shares of GeneDx Dropped Wednesday
March 22, 2023
The potential of a reverse split concerned investors.
Via
The Motley Fool
GeneDx to Participate in Upcoming Investor Conferences in June
May 24, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
May 23, 2023
Keynote session to highlight value of GeneDx genomic data and clinical insights to accelerate genetic neurodevelopmental disorder pipeline for Mahzi Therapeutics
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 22, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Holdings's Earnings: A Preview
March 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 12, 2023
On Friday, 199 companies reached new 52-week lows.
Via
Benzinga
GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
May 09, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
May 04, 2023
New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
May 03, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Why GeneDx Holdings Stock Lagged the Market Today
April 28, 2023
A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.
Via
The Motley Fool
GeneDx Announces Reverse Stock Split
April 28, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 18, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel
April 03, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 31, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 31, 2023
It's time for another dive into the biggest pre-market stock movers with all the hot topics traders need to know about on Friday!
Via
InvestorPlace
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 21, 2023
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.
Via
Benzinga
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
March 21, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
March 20, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
The 7 Worst Stocks to Buy Now
March 18, 2023
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.
Via
InvestorPlace
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
March 16, 2023
New research released at ACMG Annual Clinical Genetics Meeting reiterates the superiority of exome sequencing’s role in shortening the diagnostic odyssey
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 14, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference
March 01, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
February 28, 2023
Research illustrates company’s progress in working to end the diagnostic odyssey and includes data with implications for how care is delivered to patients beginning at birth
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 24, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.